21Jan 2020

MECHANISM OF CIGARETTE SMOKE - INDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

  • Department of Biotechnology and Dr B C Guha Centre for Genetic Engineering and Biotechnology, University College of Science and Technology, University of Calcutta, Kolkata -700019, West Bengal, India.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Chronic Obstructive Pulmonary Diseases (COPD) is currently the third leading cause of death worldwide. COPD causes great burden to society by contributing in morbidity and productivity loss. Cigarette smoking is the primary reason for COPD in smokers. In spite of the several initiatives of the national and international public health organizations for quitting smoking, number of smokers are increasing in low- and middle-income countries continuously. For the prevention and morbidity management of this treatable disease, understanding of the pathogenic events orchestrated by cigarette smoke (CS) is required. In smokers, COPD is caused by the constant exposure of lung to harmful components of CS. Oxidative stress plays the central role in CS-induced COPD pathogenesis in smokers along with other important components of COPD pathogenesis, such as lung injury, lung inflammation, protease-antiprotease imbalance, small airway remodeling and apoptosis. In this review we tried to briefly summarize the mechanisms behind the CS-induced pathogenesis for COPD which follow a complex network of events.

  1. Aoshiba K, Yasuda K, Yasui S, Tamaoki J and Nagai A (2001) Serine proteases increase oxidative stress in lung cells. Am. J. Physiol. Lung Cell Mol. Physiol. 281(3) pp.L556-L564
  2. Arner ESJ and Holmgren A (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267(20) pp6102?9
  3. Centers for Disease Control and Prevention (2011) Public Health Strategic Framework for COPD Prevention. Atlanta, GA: Centers for Disease Control and Prevention (Available at www.cdc.gov/copd)
  4. Churg A, Cosio M and Wright JL (2008) Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am. J. Physiol. Lung Cell Mol. Physiol. 294(4) pp.L612-L631
  5. Di Stefano A, Caramori G, Oates T, Capelli A, Lusuardi M, Gnemmi I, Ioli F, Chung KF et al (2002) Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD. Eur. Respir. J. 20(3) pp556?63
  6. Eriksen M, Mackay J, Schluger N, Gomeshtapeh F and Drope J (2015) The Tobacco Atlas. 5ed: Revised, Expanded, and Updated (Atlanta, USA)
  7. Gutteridge JM (1994) Biological origin of free radicals, and mechanisms of antioxidant protection. Chem. Biol. Interact. 91(2) pp133-140
  8. Hodge SJ, Hodge GL, Reynolds PN, Scicchitano R and Holmes M (2003) Increased production of TGF-β and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am. J. Physiol. Lung Cell Mol. Physiol. 285(2) pp.L492-L499
  9. Hogg JC (2004) Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364(9435) pp709?21
  10. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC and Voelkel NF (2001) Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med.163(3) pp.737-744
  11. Kinnula VL and Crapo JD (2003) Superoxide dismutases in the lung and human lung diseases Am. J. Respir. Crit. Care Med. 167(12), pp.1600-1619
  12. Laniado-Labor?n R (2009) Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21st century. Int. J. Environ. Res. Public Health 6(1) pp.209-224
  13. Li XY, Donaldson K, Rahman I and MacNee W (1994) An investigation of the role of glutathione in increased epithelial permeability induced by cigarette smoke in vivo and in vitro. Am. J. Respir. Crit. Care Med. 149(6) pp1518?25
  14. Majo J, Ghezzo H and Cosio MG (2001) Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur. Respir. J. 17(5) pp.946-953
  15. Martin LD, Krunkosky TM, Voynow JA and Adler KB (1998) The role of reactive oxygen and nitrogen species in airway epithelial gene expression. Environ. Health. Perspect. 106 Suppl 5 pp1197?1203
  16. Mathers CD and Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS. Med. 3(11): e442
  17. Mendis S, Puska P, Norrving B and World Health Organization (2011) Global atlas on cardiovascular disease prevention and control Geneva: World Health Organization
  18. Mercer BA, Lemaitre V, Powell CA and D?Armiento J (2006) The epithelial cell in lung health and emphysema pathogenesis. Curr. Resp. Med. Rev. 2(2) pp101?142
  19. Parks WC and Shapiro (2000) Matrix metalloproteinases in lung biology. Respir. Res.2(1) pp.10-19
  20. Peto R, Lopez AD, Boreham J, Thun M, and Heatch C (1992) Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 339(8804) pp1268-1278
  21. Postma DS and Timens W (2006) Remodeling in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 3(5) pp.434-439
  22. Profita M, Chiappara G, Mirabella F, Di Giorgi R, Chimenti L, Costanzo G, Riccobono L, Bellia V et al (2003) Effect of cilomilast (Ariflo) on TNF-α, IL-8, and GM-CSF release by airway cells of patients with COPD. Thorax 58(7) pp573?9
  23. Rahman I and MacNee W (1998) Role of transcription factors in inflammatory lung diseases. Thorax 53(7) pp 601-612
  24. Rahman I and MacNee W (2000) Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic. Biol. Med. 28(9) pp1405-1420
  25. Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF and Flores SC (2003) Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am. J. Respir. Cell Mol. Biol. 29(1), pp 88-97
  26. S. Department of Health and Human Services (2010) How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Office on Smoking and Health Atlanta (USA)
  27. S. Department of Health and Human Services (2014) The Health Consequences of smoking- 50 years of progress; A report of the Surgeon General. Department of Health and Human Services. Public Health Service. US Office of the Surgeon General
  28. US Department of Health and Human Services (1983) The Health Consequences of Smoking: Cardiovascular Disease. A Report of the Surgeon General. Rockville, MD, US Department of Health and Human Services. Public Health Service, Office on Smoking and Health.
  29. US Department of Health and Human Services (2004) The health consequences of smoking: a report of the Surgeon General Office of the Surgeon General (US)
  30. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R et al (2017) Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am. J. Respir. Crit. Care Med. 195(5) pp557-582
  31. World Health Organization (2018) Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2016. Geneva, World Health Organization.

[Santanu Banerjee (2020); MECHANISM OF CIGARETTE SMOKE - INDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) Int. J. of Adv. Res. 8 (Jan). 690-694] (ISSN 2320-5407). www.journalijar.com

Santanu Banerjee
Department of Biotechnology & Dr B C Guha Centre for Genetic Engineering and Biotechnology University College of Science and Technology, University of Calcutta, Kolkata -700019.

DOI:

Article DOI: 10.21474/IJAR01/10350      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10350

Download Full Paper

Download PDF No. of Downloads: 35 | No. of Views: 81